Yair Lampl

Medicine & Life Sciences

1. Stroke 100%
2. Single-Photon Emission-Computed Tomography 66%
3. Seizures 32%
4. Blood-Brain Barrier 25%
5. Brain 24%
6. Cerebrospinal Fluid 21%
7. 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane 19%
8. Pentetic Acid 19%
9. Therapeutics 17%
10. Multiple Sclerosis 16%
11. Low-Level Light Therapy 15%
12. Israel 15%
13. Infarction 14%
14. Meningeal Carcinomatosis 14%
15. National Institutes of Health (U.S.) 13%
16. Carbamazepine 12%
17. Lamotrigine 12%
18. Cerebral Hemorrhage 11%
19. Status Epilepticus 11%
20. Amnesia 11%
21. Cerebrovascular Circulation 11%
22. Simvastatin 11%
23. Hallucinations 10%
24. DP-b99 10%
25. Cerebrovascular Disorders 10%
26. Parkinsonian Disorders 10%
27. Weight Gain 10%
28. Perfusion 10%
29. Guidelines 10%
30. Valproic Acid 9%
31. Craniocerebral Trauma 9%
32. Radionuclide Imaging 9%
33. Permeability 9%
34. Anticonvulsants 9%
35. Brain Neoplasms 8%
36. Aspirin 8%
37. Glossalgia 8%
38. Giant Axonal Neuropathy 8%
39. Phenytoin 8%
40. Placebos 8%
41. Pain 8%
42. vorapaxar 8%
43. Vestibular Neuronitis 8%
44. Technetium Tc 99m Pentetate 8%
45. Peripheral Nerves 8%
46. Annexin A5 8%
47. Parkinson Disease 8%
48. lactate dehydrogenase 2 7%
49. Technetium Tc 99m Exametazime 7%
50. Secondary Prevention 7%